Immunology
Swine Flu and Tuberculosis: CEL SCI Collaborators Demonstrate Novel L.E.A.P.S. Vaccines Immunize Mice Against Tuberculosis Antigens and Suggest Potential to Treat Swine and Other InfluenzasDate:
06/05/2009
, Publication:
PharmaLive
, Author:
PRNewswire-FirstCall
http://www.pharmalive.com/News/Index.cfm?articleid=632026
Rheumatoid Arthritis: A Phase IIb Study Testing the Combination of Methotrexate and CF101 in Rheumatoid Arthritis Patients Failed to Achieve Primary Efficacy EndpointDate:
04/30/2009
, Publication:
PharmaLive.com
, Author:
Business Wire
http://pharmalive.com/news/index.cfm?articleID=622883&categoryid=9&newsletter=1
VIDEO: Swine Flu- Expect ‘additional deaths,’ CDC chief saysDate:
04/29/2009
, Publication:
MSNBC
, Author:
MSNBC
http://www.msnbc.msn.com/id/21134540/vp/30471634#30471634
Q&A: Swine Flu Myths and MysteriesDate:
04/28/2009
, Publication:
LiveScience
, Author:
Robin Lloyd, LiveScience Senior Editor
http://www.livescience.com/health/090427-flu-q-and-a.html
Swine flu: Learn about the virus found in pigs and why it is causing concern among health officials.Date:
04/27/2009
, Publication:
MSNBC
, Author:
MSNBC
http://www.msnbc.msn.com/id/30390176/
U.S. swine flu cases climb to 40Date:
04/27/2009
, Publication:
MSNBC
, Author:
msnbc.com staff
http://www.msnbc.msn.com/id/30398682/
FDA Approves Monthly Injectable Drug for Treating Three Types of Immune-Related ArthritisDate:
04/26/2009
, Publication:
FDA News
, Author:
FDA
http://www.fda.gov/bbs/topics/NEWS/2009/NEW02000.html
FDA Researchers Contribute Insights into Avian Flu Virus
Findings could help develop new tests to detect infection; new tools to study H5N1 vaccines
Date:
04/21/2009
, Publication:
FDA News
, Author:
FDA
http://www.fda.gov/bbs/topics/NEWS/2009/NEW01998.html
VIDEO: Blood Type Diet Ask Dr. Manny: Is it true that people with certain blood types should eat certain foods?Date:
03/07/2009
, Publication:
Fox News
, Author:
Fox News
http://www.foxnews.com/video2/video08.html?maven_referralObject=3771107&maven_r
Serious Infections and Neurological Events with Raptiva
Raptiva is an immunosuppressant approved as a once a week injection to treat certain adult patients with moderate to severe plaque psoriasis.
Date:
01/09/2009
, Publication:
Recalls and Safety Alerts
, Author:
FDA
http://www.accessdata.fda.gov/scripts/cdrh/cfdocs/psn/transcript.cfm?show=83#1
Previous
Page 1 of 21
Next >
Search returned 205 items.
|
Sponsored Links
Clinical Researchers, others from
subscriber lists and assoc's.
www.biotechmedia.com
Reach these Drug Developers
Via Email or Mail List Rentals
www.biotechmedia.com
This twice-monthly news magazine
reports on all phases of pharmacy
www.drugtopics.com
|